BBVA USA’s Exelon EXC Stock Holding History

BBVA USA’s Portfolio EXC Stock Details EXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$69K	Sell	1,992 -223	-10%	-$7.62K	﹤0.01%	603
2021 Q2	$70K	Buy	+2,215	New	+$71.3K	﹤0.01%	619

Other funds holding EXC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BBVA USA's EXC Position: Q3 2021 in Review

BBVA USA reduced its Exelon (EXC) stake by 10% in Q3 2021, selling an estimated $7.62K and leaving 1,992 shares worth $69K. The position accounts for ﹤0.01% of the portfolio, ranked #603.

BBVA USA first reported a position in EXC in Q2 2021 and has held it in 2 quarters since. The position peaked at $70K in Q2 2021. 933 funds tracked by Wall St. Rank hold EXC as of Q3 2021.

BBVA USA held 1,992 shares of Exelon worth $69K as of Q3 2021.
BBVA USA sold 223 Exelon shares in Q3 2021, an estimated $7.62K.
Exelon made up ﹤0.01% of BBVA USA's portfolio in Q3 2021, its #603 holding.
BBVA USA first reported a position in Exelon in Q2 2021 and has held it in 2 quarters since.
BBVA USA's Exelon position peaked at $70K in Q2 2021.
933 funds tracked by Wall St. Rank held Exelon as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.